Hims & Hers Health (HIMS) Current Leases (2021 - 2026)
Hims & Hers Health (HIMS) reported Current Leases of $5.6 million for Q1 2026, up 49.33% on a YoY basis from $3.7 million in Q1 2025, and up 15.2% sequentially from $4.8 million in Q4 2025.
Hims & Hers Health (HIMS) Current Leases (2021 - 2026) Analysis & Trends
Hims & Hers Health (HIMS) has 6 years of Current Leases data on file, last reported at $5.6 million in Q1 2026.
- For the quarter ending Q1 2026, Current Leases rose 49.33% year-over-year to $5.6 million; the trailing twelve-month figure through Mar 2026 stood at $5.6 million (up 49.33% YoY), and the FY2025 full-year result was $4.8 million, up 156.38% from the prior year.
- Current Leases advanced to $5.6 million in Q1 2026, from $4.8 million in the prior quarter.
- In the past five years, Current Leases ranged from a high of $5.6 million in Q1 2026 to a low of $1.3 million in Q4 2023.
- A 5-year average of $2.4 million and a median of $1.8 million in 2024 frame the typical range for Current Leases.
- Across the five-year window, Current Leases slipped 22.74% in 2023 and jumped 156.38% in 2025, its largest moves.
- Tracing HIMS's Current Leases over 5 years: stood at $1.7 million in 2022, then fell by 22.74% to $1.3 million in 2023, then jumped by 47.46% to $1.9 million in 2024, then soared by 156.38% to $4.8 million in 2025, then climbed by 15.2% to $5.6 million in 2026.
- Business Quant data shows HIMS's Current Leases at $5.6 million in Q1 2026, $4.8 million in Q4 2025, and $3.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | - |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | 170,000.00 |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | - |
| 10 | Hims & Hers Health | 6.44 Bn | 5.69 Bn | 396.79 Mn | 5.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.58 Mn |
| Dec 31, 2025 | 4.84 Mn |
| Sep 30, 2025 | 3.42 Mn |
| Jun 30, 2025 | 3.14 Mn |
| Mar 31, 2025 | 3.74 Mn |
| Dec 31, 2024 | 1.89 Mn |
| Sep 30, 2024 | 1.79 Mn |
| Jun 30, 2024 | 1.63 Mn |
| Mar 31, 2024 | 1.54 Mn |
| Dec 31, 2023 | 1.28 Mn |
| Sep 30, 2023 | 1.93 Mn |
| Jun 30, 2023 | 1.80 Mn |
| Mar 31, 2023 | 1.70 Mn |
| Dec 31, 2022 | 1.66 Mn |
| Sep 30, 2022 | 1.61 Mn |
| Jun 30, 2022 | 1.40 Mn |
| Mar 31, 2022 | 1.39 Mn |
| Dec 31, 2021 | 1.37 Mn |